1. Home
  2. BIAF vs KRKR Comparison

BIAF vs KRKR Comparison

Compare BIAF & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • KRKR
  • Stock Information
  • Founded
  • BIAF 2014
  • KRKR 2010
  • Country
  • BIAF United States
  • KRKR China
  • Employees
  • BIAF N/A
  • KRKR N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • KRKR Business Services
  • Sector
  • BIAF Health Care
  • KRKR Consumer Discretionary
  • Exchange
  • BIAF Nasdaq
  • KRKR Nasdaq
  • Market Cap
  • BIAF 12.2M
  • KRKR 11.7M
  • IPO Year
  • BIAF 2022
  • KRKR 2019
  • Fundamental
  • Price
  • BIAF $0.29
  • KRKR $5.78
  • Analyst Decision
  • BIAF Hold
  • KRKR
  • Analyst Count
  • BIAF 1
  • KRKR 0
  • Target Price
  • BIAF N/A
  • KRKR N/A
  • AVG Volume (30 Days)
  • BIAF 11.2M
  • KRKR 2.7K
  • Earning Date
  • BIAF 08-13-2025
  • KRKR 03-11-2025
  • Dividend Yield
  • BIAF N/A
  • KRKR N/A
  • EPS Growth
  • BIAF N/A
  • KRKR N/A
  • EPS
  • BIAF N/A
  • KRKR N/A
  • Revenue
  • BIAF $8,809,228.00
  • KRKR $31,657,328.00
  • Revenue This Year
  • BIAF N/A
  • KRKR $182.55
  • Revenue Next Year
  • BIAF $20.00
  • KRKR N/A
  • P/E Ratio
  • BIAF N/A
  • KRKR N/A
  • Revenue Growth
  • BIAF 78.40
  • KRKR N/A
  • 52 Week Low
  • BIAF $0.16
  • KRKR $2.76
  • 52 Week High
  • BIAF $2.99
  • KRKR $12.99
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 50.96
  • KRKR 53.05
  • Support Level
  • BIAF $0.22
  • KRKR $5.55
  • Resistance Level
  • BIAF $0.46
  • KRKR $5.88
  • Average True Range (ATR)
  • BIAF 0.04
  • KRKR 0.09
  • MACD
  • BIAF 0.01
  • KRKR -0.04
  • Stochastic Oscillator
  • BIAF 30.51
  • KRKR 38.98

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

Share on Social Networks: